It displays immunomodulating and antineoplastic activities by inhibiting IDO1, leading to decreased kynurenine levels and restoring proliferation and activation of immune cells suppressed in many cancers (Dhiman et al., 2017). This evidence concerns the gene IDO1 and cancer.